Individuals with UHL/SSD can now seek treatment with a cochlear implant from Cochlear to hear with both ears Lone Tree, Colo. (January 11, 2022) — Cochlear Limited (ASX: COH), the global […]
We are excited to announce that Cochlear has received the U.S. Food and Drug Administration’s (FDA) approval of the new Cochlear™ Nucleus® Kanso® 2 off-the-ear Sound Processor (CP1150). We have […]
A new AudiologyOnlinecourse is now open for registration: The Evolution of Pediatric Candidacy for Cochlear Implants: A New Indication This course will discuss hearing loss from a pediatric patient treatment […]
Amid COVID-19 pandemic, remote healthcare solutions are a priority now more than ever Centennial, Colo. (April 7, 2020) — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained […]
End of content
No more pages to load
